Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Loane

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
European Journal of Medical Genetics|May 14, 2018
Prevalence of valproate syndrome in Europe from 2005 to 2014: A registry based multi-centre studyJoan K Morris, Ester Garne, Maria Loane, et al.
European Journal of Clinical Pharmacology|February 26, 2025
Antiretroviral drug exposure in pregnancy and risk of congenital anomalies: a European case/non-case malformed studyLaura Saint-Lary, Anna-Belle Beau, Agnès Sommet, et al.
BMJ Open|July 27, 2023
Ethics and legal requirements for data linkage in 14 European countries for children with congenital anomaliesHugh Claridge, Joachim Tan, Maria Loane, et al.
British Journal of Clinical Pharmacology|July 1, 2026
Case-malformed signal detection and prioritisation using EUROmediCAT data for pharmacovigilance in pregnancyHannah Johnson, Helen Dolk, Maria Loane, et al.
Archives of Disease in Childhood|February 19, 2024
Hospital care in the first 10 years of life of children with congenital anomalies in six European countries: data from the EUROlinkCAT cohort linkage studyJoan K Morris, Maria Loane, Charlotte Wahlich, et al.
British Journal of Clinical Pharmacology|June 30, 2016
EUROmediCAT signal detection: a systematic method for identifying potential teratogenic medicationJohannes M Luteijn, Joan K Morris, Ester Garne, et al.
British Journal of Clinical Pharmacology|March 31, 2016
EUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associationsJoanne E Given, Maria Loane, Johannes M Luteijn, et al.
Plos One|July 22, 2022
Hospital length of stay among children with and without congenital anomalies across 11 European regions-A population-based data linkage studyStine Kjaer Urhoj, Joachim Tan, Joan K Morris, et al.
European Journal of Human Genetics : EJHG|June 21, 2012
Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screeningMaria Loane, Joan K Morris, Marie-Claude Addor, et al.
Plos One|August 30, 2023
Creating a population-based cohort of children born with and without congenital anomalies using birth data matched to hospital discharge databases in 11 European regions: Assessment of linkage success and data qualityMaria Loane, Joanne E Given, Joachim Tan, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
European Journal of Medical Genetics|May 14, 2018
Prevalence of valproate syndrome in Europe from 2005 to 2014: A registry based multi-centre studyJoan K Morris, Ester Garne, Maria Loane, et al.
European Journal of Clinical Pharmacology|February 26, 2025
Antiretroviral drug exposure in pregnancy and risk of congenital anomalies: a European case/non-case malformed studyLaura Saint-Lary, Anna-Belle Beau, Agnès Sommet, et al.
BMJ Open|July 27, 2023
Ethics and legal requirements for data linkage in 14 European countries for children with congenital anomaliesHugh Claridge, Joachim Tan, Maria Loane, et al.
British Journal of Clinical Pharmacology|July 1, 2026
Case-malformed signal detection and prioritisation using EUROmediCAT data for pharmacovigilance in pregnancyHannah Johnson, Helen Dolk, Maria Loane, et al.
Archives of Disease in Childhood|February 19, 2024
Hospital care in the first 10 years of life of children with congenital anomalies in six European countries: data from the EUROlinkCAT cohort linkage studyJoan K Morris, Maria Loane, Charlotte Wahlich, et al.
British Journal of Clinical Pharmacology|June 30, 2016
EUROmediCAT signal detection: a systematic method for identifying potential teratogenic medicationJohannes M Luteijn, Joan K Morris, Ester Garne, et al.
British Journal of Clinical Pharmacology|March 31, 2016
EUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associationsJoanne E Given, Maria Loane, Johannes M Luteijn, et al.
Plos One|July 22, 2022
Hospital length of stay among children with and without congenital anomalies across 11 European regions-A population-based data linkage studyStine Kjaer Urhoj, Joachim Tan, Joan K Morris, et al.
European Journal of Human Genetics : EJHG|June 21, 2012
Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screeningMaria Loane, Joan K Morris, Marie-Claude Addor, et al.
Plos One|August 30, 2023
Creating a population-based cohort of children born with and without congenital anomalies using birth data matched to hospital discharge databases in 11 European regions: Assessment of linkage success and data qualityMaria Loane, Joanne E Given, Joachim Tan, et al.
Pageof 13